Clik here to view.
Trump drug pricing tweet sends pharma stocks down
Shares in Pfizer (NYSE:PFE), Merck (NYSE:MRK) and Amgen (NSDQ:AMGN) fell slightly this morning after President Donald Trump tweeted that he was working on a “new system” to lower drug prices. “I am...
View ArticleClik here to view.
Researchers develop cargo-carrying red blood cells to improve MS and T1D in mice
Researchers from the Whitehead Institute for Biomedical Research modified red blood cells with disease-specific antigens to prevent and alleviate multiple sclerosis and Type I diabetes in early stage...
View ArticleClik here to view.
Pacira prices $300m senior notes offering
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it priced $300 million of convertible 2.375% senior notes due 2022 in a private placement to qualified institutional buyers. The Parsippany,...
View ArticleClik here to view.
PharmaJet, Serum Institute partner for needle-free MMR vaccine
PharmaJet inked a partnership with vaccine manufacturer Serum Institute of India to commercialize needle-free delivery of the MMR vaccine using the Stratis 0.5mL injection system. PharmaJet’s device is...
View ArticleClik here to view.
Novo Nordisk approaches Global Blood Therapeutics for possible takeover
Insulin giant Novo Nordisk (NYSE:NVO) has reportedly approached Global Blood Therapeutics (NSDQ:GBT) to discuss a possible takeover. The U.S. biotech is reviewing its options with an investment bank,...
View ArticleClik here to view.
PolyPid wins FDA designation for antibiotic drug reservoir
Pharmaceutical company PolyPid said today that its D-Plex antibiotic drug reservoir won Qualified Infectious Disease Product status from the FDA. Under the designation, the Israel-based company’s...
View ArticleClik here to view.
Tandem looks to raise $50m in public offering; shares fall despite Q4...
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell today, although the medical device maker met expectations on Wall Street with its 4th quarter results. The San Diego-based company posted losses of...
View ArticleClik here to view.
Study: Streamlined regulatory pathway has not shortened approval times for drugs
A study published by the Tufts Center for the Study of Drug Development found that the streamlined 505(b)(2) approval process for new drug applications in the U.S. has not led to shorter approval...
View ArticleClik here to view.
Grassley questions Auvi-Q’s list price, while Trump shows support for...
Although Mylan (NSDQ:MYL) has been under fire for its pricey EpiPen device since August last year, competitor Kaleo found itself garnering unwanted attention from politicians this week over the price...
View ArticleClik here to view.
Sanofi, Voluntis ink deal for digital insulin management system for T2D
Sanofi (NYSE:SNY) and Voluntis said today that the groups inked a non-exclusive agreement to bring digital insulin management systems for Type II diabetes to the U.S. and several European countries....
View ArticleClik here to view.
Scientists develop microjet device for needle-free vaccine delivery
Researchers from the University of California Berkeley have developed a needle-free delivery device for vaccines. The team published their work in Science Translational Medicine. The MucoJet device is...
View ArticleClik here to view.
Trump’s pick for FDA chief faces questions over ties to drug industry
Although President Donald Trump’s nominee for FDA commissioner has won approval from lawmakers across the aisle, he is facing questions from consumer watchdog Public Citizen over his ties to the drug...
View ArticleClik here to view.
FDA announces updates to Medtronic’s Class I recall for SynchroMed drug pumps
The FDA today updated Medtronic’s Class I recall for the company’s SynchroMed II and SynchroMed EL implantable drug pumps, which were designed to locally treat primary or metastatic cancer, chronic...
View ArticleClik here to view.
Ocular touts patient experience data for Dextenza implant
Ocular Therapeutix (NSDQ:OCUL) touted data today from a patient experience study of its Dextenza post-surgical pain relief implant. The study was published in Patient Preference and Adherence. The...
View ArticleClik here to view.
Medtronic’s SynchroMed woes delay United Therapeutic’s Remodulin
Shares in United Therapeutics (NSDQ:UTHR) fell -3% yesterday on a possible delay for the release of a programmable infusion pump for its drug, Remodulin. Yesterday, the FDA updated Medtronic‘s...
View ArticleClik here to view.
FDA panel rules that benefits of Endo’s Opana opioid no longer outweigh risks
An FDA advisory panel ruled yesterday that the benefits of Endo Pharmaceutical‘s opioid painkiller, Opana ER, no longer outweigh its risks. The painkiller has been linked to a 2015 HIV outbreak in...
View ArticleClik here to view.
Pharma stocks fall on Trump’s proposal to cut NIH budget
The Trump budget plan to slash more than 18% from the budget for the National Institutes of Health sent pharmaceutical stocks down today on Wall Street as investors reacted to the proposal. The budget...
View ArticleClik here to view.
Ivenix pulls down $10m tranche in $50m round
Ivenix raised $10 million in equity from 18 unnamed investors in the 1st tranche of its $50 million round, according to regulatory filings. The company indicated that it does not expect the offering to...
View ArticleClik here to view.
Under pricing pressure, insulin maker joins CVS Reduced Rx savings program
Facing pressure from lawmakers about the prices of their drugs, some pharmaceutical companies are looking for ways to make their products more affordable and more accessible. Novo Nordisk (NYSE:NVO)...
View ArticleClik here to view.
Facing pressure from pharma, FDA delays off-label promotion rule
After pharmaceutical industry groups filed a petition against the FDA’s new off-label promotion rule, the federal watchdog agency said last week it would delay the rule’s implementation to March 19,...
View Article